Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,636 | 9,432 | 19,993 | 32,948 | 7,143 |
| Marketable Securities | N/A | N/A | 433 | 904 | 675 |
| Receivables | 1,613 | 484 | 2,012 | 1,437 | 203 |
| Inventories | 410 | N/A | N/A | N/A | N/A |
| Other current assets | 279 | 139 | 2,121 | 2,953 | 0 |
| TOTAL | $11,759 | $10,698 | $25,536 | $39,143 | $9,226 |
| Non-Current Assets | |||||
| PPE Net | 3,567 | 3,799 | 8,672 | 5,590 | 3,262 |
| Investments And Advances | 0 | 0 | 0 | 0 | 13,417 |
| Intangibles | 14,607 | 56,595 | 61,633 | 80,405 | 24,196 |
| Other Non-Current Assets | 5,148 | 3,800 | 4,250 | 34,425 | 5,318 |
| TOTAL | $23,322 | $64,194 | $74,555 | $120,420 | $46,193 |
| Total Assets | $35,081 | $74,892 | $100,091 | $159,563 | $55,419 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,279 | 953 | 1,253 | 1,810 | 432 |
| Accrued Expenses | 3,473 | 3,217 | 8,033 | 8,652 | 5,752 |
| Other current liabilities | 228 | 2,314 | N/A | N/A | N/A |
| TOTAL | $7,275 | $7,194 | $12,106 | $14,120 | $8,996 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 1,508 |
| Other Non-Current Liabilities | 40,080 | 47,230 | 53,693 | 80,226 | 11,432 |
| TOTAL | $40,080 | $47,230 | $53,693 | $80,226 | $12,940 |
| Total Liabilities | $47,355 | $54,424 | $65,799 | $94,346 | $21,936 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,599 | 8,273 | 5,964 | 4,612 | 4,446 |
| Common Shares | 338,244 | 310,295 | 294,929 | 252,954 | 157,160 |
| Retained earnings | -350,539 | -289,876 | -260,676 | -187,774 | -123,677 |
| Other shareholders' equity | 21 | 49 | 39 | 37 | 0 |
| TOTAL | $-12,274 | $20,468 | $34,292 | $65,217 | $33,483 |
| Total Liabilities And Equity | $35,081 | $74,892 | $100,091 | $159,563 | $55,419 |